1.Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, Lynfield R, Maloney M, McAllister-Hollod L, Nadle J et al: Multistate point-prevalence survey of health care-associated infections. The New England journal of medicine 2014, 370(13):1198–1208.
2.Hardak E, Avivi I, Berkun L, Raz-Pasteur A, Lavi N, Geffen Y, Yigla M, Oren I: Polymicrobial pulmonary infection in patients with hematological malignancies: prevalence, co-pathogens, course and outcome. Infection 2016, 44(4):491–497.
3.Jain S, Self WH, Wunderink RG, Fakhran S, Balk R, Bramley AM, Reed C, Grijalva CG, Anderson EJ, Courtney DM et al: Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults. The New England journal of medicine 2015, 373(5):415–427.
4.Labelle AJ, Arnold H, Reichley RM, Micek ST, Kollef MH: A comparison of culture-positive and culture-negative health-care-associated pneumonia. Chest 2010, 137(5):1130–1137.
5.Gu W, Miller S, Chiu CY: Clinical Metagenomic Next-Generation Sequencing for Pathogen Detection. Annual review of pathology 2019, 14:319–338.
6.Miao Q, Ma Y, Wang Q, Pan J, Zhang Y, Jin W, Yao Y, Su Y, Huang Y, Wang M et al: Microbiological Diagnostic Performance of Metagenomic Next-generation Sequencing When Applied to Clinical Practice. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 2018, 67(suppl_2):S231-s240.
7.Li H, Gao H, Meng H, Wang Q, Li S, Chen H, Li Y, Wang H: Detection of Pulmonary Infectious Pathogens From Lung Biopsy Tissues by Metagenomic Next-Generation Sequencing. Frontiers in cellular and infection microbiology 2018, 8:205.
8.Li H, Durbin R: Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics (Oxford, England) 2009, 25(14):1754–1760.
9.Wang J, Xu H, Li Z, Li F, Yang Y, Yu X, Jiang D, Xing L, Sun H, Shao M: Pathogens in patients with granulomatous lobular mastitis. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 2019, 81:123–127.
10.De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA et al: Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 2008, 46(12):1813–1821.
11.Guan H, Shen A, Lv X, Yang X, Ren H, Zhao Y, Zhang Y, Gong Y, Ni P, Wu H et al: Detection of virus in CSF from the cases with meningoencephalitis by next-generation sequencing. Journal of neurovirology 2016, 22(2):240–245.
12.Patterson TF, Thompson GR, 3rd, Denning DW, Fishman JA, Hadley S, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Nguyen MH et al: Executive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 2016, 63(4):433–442.
13.Toma I, Siegel MO, Keiser J, Yakovleva A, Kim A, Davenport L, Devaney J, Hoffman EP, Alsubail R, Crandall KA et al: Single-molecule long-read 16S sequencing to characterize the lung microbiome from mechanically ventilated patients with suspected pneumonia. Journal of clinical microbiology 2014, 52(11):3913–3921.
14.Holder KA, Grant MD: Human cytomegalovirus IL–10 augments NK cell cytotoxicity. Journal of leukocyte biology 2019.
15.Chiche L, Forel JM, Roch A, Guervilly C, Pauly V, Allardet-Servent J, Gainnier M, Zandotti C, Papazian L: Active cytomegalovirus infection is common in mechanically ventilated medical intensive care unit patients. Critical care medicine 2009, 37(6):1850–1857.
16.Grahame-Clarke C, Chan NN, Andrew D, Ridgway GL, Betteridge DJ, Emery V, Colhoun HM, Vallance P: Human cytomegalovirus seropositivity is associated with impaired vascular function. Circulation 2003, 108(6):678–683.
17.Limaye AP, Boeckh M: CMV in critically ill patients: pathogen or bystander? Reviews in medical virology 2010, 20(6):372–379.
18.Phair J, Munoz A, Detels R, Kaslow R, Rinaldo C, Saah A: The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group. The New England journal of medicine 1990, 322(3):161–165.
19.Avino LJ, Naylor SM, Roecker AM: Pneumocystis jirovecii Pneumonia in the Non-HIV-Infected Population. The Annals of pharmacotherapy 2016, 50(8):673–679.
20.Maini R, Henderson KL, Sheridan EA, Lamagni T, Nichols G, Delpech V, Phin N: Increasing Pneumocystis pneumonia, England, UK, 2000–2010. Emerging infectious diseases 2013, 19(3):386–392.
21.Schildgen V, Mai S, Khalfaoui S, Lusebrink J, Pieper M, Tillmann RL, Brockmann M, Schildgen O: Pneumocystis jirovecii can be productively cultured in differentiated CuFi–8 airway cells. mBio 2014, 5(3):e01186–01114.
22.Merali S, Frevert U, Williams JH, Chin K, Bryan R, Clarkson AB, Jr.: Continuous axenic cultivation of Pneumocystis carinii. Proceedings of the National Academy of Sciences of the United States of America 1999, 96(5):2402–2407.
23.Sobolewska A, Dzbenski TH: In vitro cultivation of Pneumocystis isolated from infected rat lungs. Wiadomosci parazytologiczne 2009, 55(4):451–457.
24.Huang MJ, An YJ, Li SZ, Lu SQ, Guo ZZ: [Continuous axenic cultivation of Pneumocystis carinii isolated from the bronchoalveolar lavage fluid of infected rat]. Zhongguo ji sheng chong xue yu ji sheng chong bing za zhi = Chinese journal of parasitology & parasitic diseases 2007, 25(2):129–132, 136.